Evidence map›Paper›PMID 25754871›Full record

ArticleJournal of hospital medicine2015

Willingness to access an in-hospital supervised injection facility among hospitalized people who use illicit drugs.

Lianping Ti, Jane Buxton, Scott Harrison, Sabina Dobrer, Julio Montaner, Evan Wood, Thomas Kerr

Open access · greenAbstract read
In one paragraph

Article in Journal of hospital medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. The impact of the COVID-19 pandemic on access to supervised consumption programs.Substance abuse treatment, prevention, and policy · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Against Medical Advice Discharges in Injection and Non-injection Drug Use-associated Infective Endocarditis: A Nationwide Cohort Study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
  10. Article
  11. Article
  12. Review
  13. Supervised consumption services for acute care hospital patients.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2020
    Article
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Lianping TiBritish Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, Vancouver, British Columbia, Canada; School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.
Jane Buxton
Scott Harrison
Sabina Dobrer
Julio Montaner
Evan Wood
Thomas Kerr
St. Paul's Hospital · CAUniversity of British Columbia · CAAIDS Vancouver · CAProvidence Health Care · CA

Funding

Vancouver Drug Users Study: The Impacts of Evolving Drug Use Patterns on HIV/AIDSU01DA038886 · NIDA · UNIVERSITY OF BRITISH COLUMBIA · PI DEBECK, KORA, HAYASHI, KANNA · 2015 to 2024
$12.1M
SYRINGE ACCESS AND RISK FACTORS ON HIV TRANSMISSIONR01DA011591 · NIDA · UNIVERSITY OF BRITISH COLUMBIA · PI KERR, THOMAS · 1998 to 2014
$5.9M
Impacts of universal access to HIV/AIDS care among HIV+ injection drug usersR01DA021525 · NIDA · UNIVERSITY OF BRITISH COLUMBIA · PI MILLOY, M-J · 2007 to 2016
$5.8M
HIV Risk Environments among FSW and DU: A Longitudinal Ethno-Spatial ApproachR01DA033147 · NIDA · UNIVERSITY OF BRITISH COLUMBIA · PI KERR, THOMAS, SHANNON, KATE · 2012 to 2016
$1.8M
Canadian Institutes of Health Research MOP-111039NIDA NIH HHS R01 DA011591NIDA NIH HHS R01DA011591NIDA NIH HHS R01 DA021525NIDA NIH HHS R01DA021525NIDA NIH HHS R01 DA033147NIDA NIH HHS U01 DA038886
6 · The paper itself

Abstract

backgroundDespite the reliance on abstinence-based drug policies within hospital settings, illicit drug use is common among hospitalized patients with severe drug addiction. Hospitalized patients who use illicit drugs (PWUDs) have been known to resort to high-risk behavior to conceal their drug use from healthcare providers. Novel interventions with the potential to reduce high-risk behavior among PWUDs in hospital settings have not been well studied.

objectiveThe objective of the study was to examine factors associated with willingness to access an in-hospital supervised injection facility (SIF).

designData were derived from participants enrolled in 2 Canadian prospective cohort studies involving PWUDs between June 2013 and November 2013. A cross-sectional study surveying various sociodemographic characteristics, drug use patterns, and experiences was conducted.

settingVancouver, Canada. MEASUREMENTS: Bivariable and multivariable logistic regression analyses were used to explore factors significantly associated with willingness to access an in-hospital SIF.

resultsAmong 732 participants, 499 (68.2%) would be willing to access an in-hospital SIF. In multivariable analyses, factors positively and significantly associated with willingness to access an in-hospital SIF included: daily heroin injection (adjusted odds ratio [AOR] = 1.90; 95% confidence interval [CI]: 1.20-3.11); having used illicit drugs in hospital (AOR = 1.63; 95% CI: 1.18-2.26); and having recently used an SIF (AOR = 1.53; 95% CI: 1.10-2.15).

conclusionsOur findings highlight the potential of in-hospital SIFs to complement existing harm reduction programs that serve PWUD. Moreover, an in-hospital SIF may minimize the harms associated with high-risk illicit drug use in the hospital.

Indexed as

HospitalizationAdultCanadaCross-Sectional StudiesDrug UsersFemaleHIV InfectionsHumansIllicit DrugsInpatientsMaleMiddle AgedNeedle-Exchange ProgramsProspective StudiesSubstance Abuse, IntravenousIllicit Drugs

Identifiers

PMID25754871
PMCPMC4412787
OpenAlexW1874935127

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.